Pegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals)

培非格司亭生物类似药（Harvest Moon Pharmaceuticals/PanPharmaceuticals）

Report date: 2022/01/21 13:30:11

Base Information

Drug NamePegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals)
Drug Alias Name培非司亭生物仿制药（Harvest Moon Pharmaceuticals）Pegfilgrastimum (Harvest Moon Pharmaceuticals/PanPharmaceuticals)聚乙二醇化非格司亭生物仿制药（Harvest Moon Pharmaceuticals/PanPharmaceuticals）培非拉司亭生物仿制药（Harvest Moon Pharmaceuticals/PanPharmaceuticals）聚乙二醇非格司亭生物仿制药（Harvest Moon Pharmaceuticals/PanPharmaceuticals）
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHarvest Moon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A